INS and type 1 diabetes mellitus: To use iPSC technologies, it would have to be possible to generate DiPSCs from T1DM individuals, while studying the mechanisms regarding autoimmune disease by preparing differentiated cell-types involved in pathogenesis including: thymus epithelial cells, dendritic cells, various types of T-cells, and especially insulin-secreting pancreatic β cells.